The latest news on Moderna, including vaccine, stock and share price updates
Rethink for big pharma as demand for Covid-19 vaccines falls
New UK Moderna vaccine centre to produce 250 million doses a year
Moderna will help WHO develop Covid-19 vaccine, but Pfizer declines
Moderna sues Pfizer-BioNTech for patent infringement over Covid-19 vaccine
World's first approval of 'next generation' Omicron vaccine booster
Vaccinations for children under 5 begin in US
Moderna's Q1 profit soars as Covid-19 vaccine sales boost revenue
Moderna seeks Covid vaccine authorisation for US children under 5
Moderna ‘plans major investment deal in UK research and manufacturing’
Moderna starts study of Omicron-specific vaccine booster shot
Fourth booster shot less effective against Omicron, Israel research finds
Dual vaccine to fight Covid and flu 'likely' next year, WEF hears
Moderna vaccine order for 2022 hits £13.6 billion
Moderna says Omicron booster could be ready by March
Don't freak out over Omicron, says BioNTech chief
No, AstraZeneca can’t claim that T-cells trump antibodies in the fight against Covid-19